miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer

(2016) Fangyuan Zou et al.   FEBS Journal

Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition

(2016) Dongsheng Huang et al.   Scientific Reports

miR-139-5p inhibits epithelial–mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2

(2015) Gongcai Qiu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Involvement of aberrant miR-139/Jun feedback loop in human gastric cancer

(2015) Yan Zhang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Constitutive expression of Bcl-2 induces epithelial-Mesenchymal transition in mammary epithelial cells

(2015) Juan An et al.   BMC CANCER

Abstract 2719: TCRP1 gene promotes NIH/3T3 cell transformation by over-activating PDPK1 and Akt

(2015) Chengkun Wang et al.   CANCER RESEARCH

MicroRNAs: Clinical Relevance in Colorectal Cancer

(2015) Joe Thomas et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity

(2015) Michael Hollis   WORLD JOURNAL OF GASTROENTEROLOGY

Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met

(2015) Chengcao Sun et al.   Oncotarget

Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species

(2015) Hong-Duck Um   Oncotarget

MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer

(2015) Lina Cekaite et al.   Oncotarget

Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Colorectal Cancer

(2015) Lei Huang et al.   MEDICINE

Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer

(2014) S H-S Lim et al.   JOURNAL OF CLINICAL PATHOLOGY

miR-139-5p is a regulator of metastatic pathways in breast cancer

(2013) K. Krishnan et al.   RNA

miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression

(2011) Jian Li et al.   CANCER LETTERS

Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: A study of hepatocellular carcinoma

(2011) Tao Sun et al.   HEPATOLOGY

Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters

(2011) M Saxena et al.   Cell Death & Disease

The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2

(2010) Carmen Chak–Lui Wong et al.   GASTROENTEROLOGY

Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers

(2010) Yeunpo Chiang et al.   JOURNAL OF GASTROINTESTINAL SURGERY

MicroRNA-Based Therapeutics for Cancer

(2009) Vivien Wang et al.   BIODRUGS

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

(2009) David J. McConkey et al.   CANCER AND METASTASIS REVIEWS

Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells

(2008) B. C. Fuchs et al.   CANCER RESEARCH

Bcl-2 family proteins and cancer

(2008) K W Yip et al.   ONCOGENE

The BCL-2 protein family: opposing activities that mediate cell death

(2007) Richard J. Youle et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY